Moderna COVID-19 Vaccine (Spikevax)

Search results

- Moderna wins second product approval with RSV vaccine
  Market Watch· 4 hours ago
  The Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
- FDA approves Moderna's RSV vaccine, its second marketed product
  USA TODAY via Yahoo News· 2 hours ago
  The Cambridge, Massachusetts-based company has been banking on its experimental shots to make up for vastly lower demand for its Spikevax COVID-
- Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
  ETF DAILY NEWS· 1 day ago
  Moderna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
- GenAI Service Market to Grow at 45% CAGR by 2033
  Analytics India Magazine· 4 days ago
  With the rise of generative AI over the last year and a half, its impact on company revenues has become increasingly evident. As per a forthcoming AIM...
- Points To Consider For Assessing Lipid Quality For Lipid Nanoparticle Manufacturing
  BioresearchOnline· 3 days ago
  Lipid nanoparticles have generated a ton of buzz, but they pose risks that, perhaps, industry and...